Diabetic Macular Edema (DME) Not Yet Recruiting Phase 4 Trials for Faricimab (DB15303)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05610488Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to AfliberceptTreatment